Live Breaking News & Updates on Low Dose Therapeutic Strategy

Stay updated with breaking news from Low dose therapeutic strategy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Actinium Pharmaceuticals, Inc. Announces Participation in Two Panel Discussions at the 3rd Targeted Radiopharmaceuticals Summit

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for. ....

Hans Vitzthum , Mary Chen , Helen Kotanides , Preclinical Development , Lifesci Advisors , Exchange Commission , Months Of Development Alpha Emitting Therapies , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , Translational Research , Clinical Development , Memorial Sloan Kettering Cancer Center , Actinium Pharmaceuticals , Targeted Radiopharmaceuticals Summit , Targeted Radiopharmaceuticals , Alpha Emitting Therapies , Next Generation Alpha Emitter Based , Expert Speaker , Vice President , High Dose , Low Dose Therapeutic Strategy , Optimizing Treatment , Antibody Radiation Conjugates , Bone Marrow Transplant , Gene Therapy , Adoptive Cell Therapy ,